# Viral Vector Core (VVC)

> **NIH NIH P30** · SALK INSTITUTE FOR BIOLOGICAL STUDIES · 2024 · $110,812

## Abstract

PROJECT SUMMARY – VIRAL VECTOR
Utilization of recombinant viral vectors are the method of choice for targeted, rapid, and regulated gene delivery
in many experimental systems. Access to this technology allows Salk Cancer Center (SCC) scientists to control
genetic activity in cells or in whole animals with the goal of better understanding fundamental cellular functions
and the molecular underpinnings of cancer and other disease processed. The Viral Vector Shared Resource
(VVC) specializes in the design, development, and production of high quality in vitro- and in vivo-grade
recombinant viral vectors. It offers convenient ready-to-use stocks, as well as custom preparations of lentiviral
vectors, retroviral vectors, adenoviral vector, adeno-associated viral vectors (AAVs), vesicular stomatitis viral
vectors (VSVs), and rabies vectors. In addition to providing these vector stocks and custom production services,
the VVC also maintains a plasmid archive of all viral vectors that have been submitted to the Shared Resource.
The plasmid library of packaging plasmids and transfer plasmids for our stock vectors is available at no cost to
SCC investigators as a resource for cloning purposes or for packaging viral vector constructs in their own. The
VVC is used by 35% of SCC members (11) who are responsible for 62% of all Salk utilization based on
recharges. The VVC is located a short walk from the Salk Institute in the Sanford Consortium for Regenerative
Medicine building (SCRM). Relocation of the VVC to SCRM, along with subsidized rates for Cancer Center
members, were designed to promote shared resource usage and collaborations among the C3 member
institutions on the mesa (see Overall: Transdisciplinary Collaboration for C3 description).

## Key facts

- **NIH application ID:** 10769676
- **Project number:** 2P30CA014195-51
- **Recipient organization:** SALK INSTITUTE FOR BIOLOGICAL STUDIES
- **Principal Investigator:** TONY R. HUNTER
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $110,812
- **Award type:** 2
- **Project period:** 1996-12-31 → 2029-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10769676

## Citation

> US National Institutes of Health, RePORTER application 10769676, Viral Vector Core (VVC) (2P30CA014195-51). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10769676. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*